Lindsay Frazier

Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.

Konneh B, Lafin JT, Howard J, Gerald T, Amini A, Savelyeva A, Woldu SL, Lewis CM, Jia L, Margulis V, Coleman N, Scarpini C, Frazier AL, Murray MJ, Amatruda JF, Bagrodia A.

Andrology. 2022 Oct 18. PMID: 36254623

Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.

Fonseca A, Lobo J, Hazard FK, Gell J, Nicholls PK, Weiss RS, Klosterkemper L, Volchenboum SL, Nicholson JC, Frazier AL, Amatruda JF, Bagrodia A, Lockley M, Murray MJ.

Br J Cancer. 2022 11. 127(9):1577-1583. PMID: 36229581

Response to commentary re: Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's oncology group.

Singla N, Wong J, Singla S, Krailo M, Huang L, Shaikh F, Billmire D, Rescorla F, Ross J, Dicken B, Amatruda JF, Frazier AL, Bagrodia A.

J Pediatr Urol. 2022 Aug. 18(4):513-514. PMID: 35868999

Predicted leukocyte telomere length and risk of germ cell tumours.

Cigan SS, Meredith JJ, Kelley AC, Yang T, Langer EK, Hooten AJ, Lane JA, Cole BR, Krailo M, Frazier AL, Pankratz N, Poynter JN.

Br J Cancer. 2022 07. 127(2):301-312. PMID: 35368045

SIOP Strategy 2021-2025: Cure for more, care for all.

Pritchard-Jones K, Challinor JM, Hunger SP, Sung L, Davidson A, Morrissey LK, Khan MS, Dalvi RB, Sullivan MJ, Hessissen L, Chantada GL, Kearns P, Frazier AL, Wollaert S, Laub T.

Pediatr Blood Cancer. 2022 06. 69(6):e29577. PMID: 35166434

Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.

Major A, Palese M, Ermis E, James A, Villarroel M, Klussmann FA, Hessissen L, Geel J, Khan MS, Dalvi R, Sullivan M, Kearns P, Frazier AL, Pritchard-Jones K, Nakagawara A, Rodriguez-Galindo C, Volchenboum SL.

JCO Glob Oncol. 2022 02. 8:e2100266. PMID: 35157510

Malignant extracranial germ cell tumours: A first national report by the South African Children's Cancer Study Group.

Hendricks M, Cois A, Geel J, du Plessis J, Bassingthwaighte M, Naidu G, Rowe B, Büchner A, Omar F, Thomas K, Uys R, van Zyl A, van Heerden J, Mahlachana N, Vermeulen J, Davidson A, Frazier AL, Donald K, Kruger M.

Pediatr Blood Cancer. 2022 05. 69(5):e29543. PMID: 34971072

Pitfalls in the diagnosis of yolk sac tumor: Lessons from a clinical trial.

Yang A, Patterson A, Pavlock T, Chen KS, Gagan J, Hatley ME, Frazier AL, Amatruda JF, Laetsch TW, Rakheja D.

Pediatr Blood Cancer. 2022 02. 69(2):e29451. PMID: 34866303

Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States.

Zhang Y, Katharina Wagner A, Du H, Han T, Gupta S, Denburg AE, Frazier AL, Guan X, Shi L.

Int J Cancer. 2022 02 01. 150(3):482-490. PMID: 34536294

Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report.

Meijer AJM, van den Heuvel-Eibrink MM, Brooks B, Am Zehnhoff-Dinnesen AG, Knight KR, Freyer DR, Chang KW, Hero B, Papadakis V, Frazier AL, Blattmann C, Windsor R, Morland B, Bouffet E, Rutkowski S, Tytgat GAM, Geller JI, Hunter LL, Sung L, Calaminus G, Carleton BC, Helleman HW, Foster JH, Kruger M, Cohn RJ, Landier W, van Grotel M, Brock PR, Hoetink AE, Rajput KM.

JAMA Oncol. 2021 Oct 01. 7(10):1550-1558. PMID: 34383016